Genomic surveillance of antimicrobial resistance in animals
Official title: Genomic surveillance for antimicrobial resistance in animals
Funded at Cornell University · NIH-11403005 · Data updated 2026-11-12
This project keeps advanced sequencing capacity online at veterinary labs to monitor antibiotic resistance in animal bacteria and protect both animal and human health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cornell University NIH-funded |
| Lab location | 1 site (Ithaca, United States) |
| Project start | August 5, 2019 |
| Project end | July 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $90,000 |
| NIH project number | 5U18FD006716-08 |
| Project ID | NIH-11403005 on NIH RePORTER |
Who could benefit from this research
✓Could help
N/A for this grant as described; outcomes primarily benefit animal and public health surveillance rather than direct patient participation.
✕Less likely to help
Direct participation by patients is not described.
What this research studies
The grant supports maintaining and validating bacterial whole-genome sequencing capabilities at Cornell to help detect antimicrobial resistance in animals. It strengthens real-time surveillance for food-borne pathogens and ensures labs can quickly characterize isolates. The effort also includes mentorship and methods sharing to improve other labs’ practices and QA documentation. By monitoring resistance in live animals, this work aims to fill a critical gap in protecting the food supply and public health.
Why it matters
Potential benefit: Strengthened ability to detect and respond to antimicrobial resistance in animals, contributing to safer food and healthier communities.
How similar studies have gone: Previous labs have demonstrated the value of genomic surveillance for tracking resistance and informing public health actions.
Where this research is happening
-
Cornell University
Ithaca, United States Active
Researchers
- Principal investigator: Goodman, Laura Brunengraber — Cornell University
- Study coordinator: Goodman, Laura Brunengraber
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.